Literature DB >> 7299845

Catechol-O-methyltransferase activity in cultured human skin fibroblasts from controls and patients with dystonia musculorum deformans.

X O Breakefield, M Braverman, D K Riker, E L Giller.   

Abstract

Fibroblasts provide a source of living cells that can be obtained easily from humans and used to evaluate inherited differences in the activities of enzymes important in neurotransmitter and drug metabolism. Here, we describe biochemical characteristics of catechol-O-methyltransferase (COMT, EC 2.1.1.6) activity in homogenates of cultured human skin fibroblasts. Many properties of the enzyme, including apparent affinity for dihydroxybenzoic acid and S-adenosyl methionine, optimal pH and (Mg++), and inhibition by Ca++, are similar to those reported in lysates of human erythrocytes. Culture and assay conditions have been established for optimal and reproducible measurement of COMT activity in individual fibroblast lines. In 16 control lines, COMT activity ranged from 115 to 263 pmol/min/mg protein with a mean of 181 pmol/min/mg protein. Enzyme activity did not vary with the age or sex of the donor. The COMT activities in fibroblasts from eight patients with dystonia musculorum deformans, an inherited movement disorder of unknown etiology, were not significantly different from controls. Monoamine oxidase (MAO, EC 1.4.3.4) type A activity was measured in 12 lines from patients with dystonia, and values did not differ significantly from age- and sex-matched controls. We conclude that inherited variation in activity of these two catabolic enzymes is not sufficient to explain alterations in monoamine metabolism described in this disorder.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299845     DOI: 10.1002/jnr.490060310

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Monoamine oxidase (MAO) activity as a determinant in human neurophysiology.

Authors:  J E Pintar; X O Breakefield
Journal:  Behav Genet       Date:  1982-02       Impact factor: 2.805

2.  Microfluidic platform to evaluate migration of cells from patients with DYT1 dystonia.

Authors:  Flavia C Nery; Nadia A Atai; Cintia C da Hora; Edward Y Kim; Jasmin Hettich; Thorsten R Mempel; Xandra O Breakefield; Daniel Irimia
Journal:  J Neurosci Methods       Date:  2014-05-29       Impact factor: 2.390

3.  Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.

Authors:  Jeffrey W Hewett; Bakhos Tannous; Brian P Niland; Flavia C Nery; Juan Zeng; Yuqing Li; Xandra O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

4.  siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.

Authors:  Jeffrey W Hewett; Flávia C Nery; Brian Niland; Pei Ge; Pamela Tan; Philipp Hadwiger; Bakhos A Tannous; Dinah W Y Sah; Xandra O Breakefield
Journal:  Hum Mol Genet       Date:  2008-02-07       Impact factor: 6.150

5.  A highly sensitive assay for monitoring the secretory pathway and ER stress.

Authors:  Christian E Badr; Jeffrey W Hewett; Xandra O Breakefield; Bakhos A Tannous
Journal:  PLoS One       Date:  2007-06-27       Impact factor: 3.240

6.  4-Phenylbutyrate attenuates the ER stress response and cyclic AMP accumulation in DYT1 dystonia cell models.

Authors:  Jin A Cho; Xuan Zhang; Gregory M Miller; Wayne I Lencer; Flavia C Nery
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.